|Acquired by||Johnson & Johnson|
|Venture Round, 3/05 |
Hercules Technology Growth Capital
Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
The company, formerly known as Omrix Biopharmaceuticals S.A., was founded in 1995 and is headquartered in New York. As of December 26, 2008, Omrix Biopharmaceuticals, Inc. operates as a subsidiary of Johnson & Johnson.